Voyager Therapeutics (VYGR) Tops Q3 EPS by 29c

Voyager Therapeutics (NASDAQ: VYGR) reported Q3 EPS of ($0.16), $0.29 better than the analyst estimate of ($0.45). Revenue for the quarter came in at $24.63 million versus the consensus estimate of $11.7 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• McDonald’s said to plan value strategy overhaul to revive US sales growth
• Huang and Altman to attend Trump-Xi state dinner - ABC
• Power Solutions (PSIX) call put ratio 1.6 calls to 1 put with a focus on September 260 calls as share price up 3%